Profile data is unavailable for this security.
About the company
Euroapi SAS is a France-based company. The Company is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. It offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. The Company also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. It has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
- Revenue in EUR (TTM)1.02bn
- Net income in EUR-189.70m
- Incorporated2020
- Employees3.67k
- LocationEuroapi SA15, rue TraversierePARIS 75012FranceFRA
- Phone+33 189206200
- Websitehttps://www.euroapi.com/en
More ▼
Mergers & acquisitions
| Acquired company | EAPI:PAR since announced | Transaction value |
|---|---|---|
| BianoGMP GmbH | -72.03% | 10.82m |
Data delayed at least 15 minutes, as of Jul 26 2024 16:36 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Niox Group PLC | 43.63m | 11.26m | 311.69m | 85.00 | 29.33 | 2.90 | 18.91 | 7.14 | 0.0211 | 0.0238 | 0.0819 | 0.2136 | 0.3874 | 2.31 | 6.13 | 432,941.20 | 10.00 | -2.41 | 10.57 | -2.90 | 72.01 | 70.87 | 25.82 | -11.46 | 3.99 | -- | 0.013 | -- | 17.57 | -5.29 | -32.62 | -- | -5.59 | -- |
| Flerie AB | 8.52k | -16.21m | 313.20m | 7.00 | -- | 0.0084 | -- | 36,769.28 | -102.92 | -102.92 | 0.0333 | 5,610.13 | 0.00004 | -- | -- | 14,285.71 | -7.86 | -37.64 | -7.99 | -41.14 | -126,944.00 | -450.51 | -190,353.00 | -454.62 | -- | -- | 0.0003 | -- | -- | 277.02 | 5.05 | -- | -- | -- |
| Ningbo Menovo Pharmaceutical Co Ltd | 156.59m | -2.26m | 314.77m | 2.35k | -- | 1.13 | -- | 2.01 | -0.1115 | -0.1115 | 5.31 | 9.99 | 0.2811 | 1.31 | 6.18 | 523,989.50 | -0.3253 | 4.94 | -0.4782 | 7.83 | 30.72 | 35.39 | -1.16 | 13.71 | 0.7935 | 0.7647 | 0.4042 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
| Jeena Sikho Lifecare Ltd | -1.10bn | -1.10bn | 316.25m | 1.23k | -- | 90.94 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Aquestive Therapeutics Inc | 47.43m | -26.49m | 320.26m | 135.00 | -- | -- | -- | 6.75 | -0.4273 | -0.4273 | 0.7836 | -0.4012 | 0.5398 | 2.78 | 6.49 | 381,496.30 | -30.15 | -76.63 | -43.46 | -123.85 | 60.23 | 64.24 | -55.85 | -102.95 | 5.85 | -3.51 | -- | -- | 6.09 | -5.59 | 85.54 | -- | -11.42 | -- |
| Euroapi SA | 1.02bn | -189.70m | 320.61m | 3.67k | -- | 0.3429 | -- | 0.3147 | -2.01 | -2.01 | 10.73 | 9.78 | 0.6086 | 1.38 | 4.24 | 277,705.10 | -11.34 | -- | -15.93 | -- | 16.15 | -- | -18.63 | -- | 0.6573 | -- | 0.1955 | -- | 3.87 | -- | -1,164.67 | -- | -- | -- |
| Morepen Laboratories Ltd | 185.92m | 10.58m | 327.31m | 1.65k | 30.97 | 3.51 | 22.88 | 1.76 | 1.88 | 1.88 | 33.11 | 16.58 | 1.41 | 4.45 | 5.74 | -- | 8.04 | 7.90 | 11.50 | 13.34 | 37.15 | 33.65 | 5.72 | 5.49 | 1.59 | 33.73 | 0.0331 | -- | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
| Indoco Remedies Ltd | 200.42m | 8.44m | 327.37m | 6.10k | 39.86 | -- | 17.09 | 1.63 | 8.10 | 8.10 | 175.95 | -- | -- | -- | -- | -- | -- | 6.88 | -- | 9.85 | 68.61 | 66.66 | 4.10 | 6.93 | -- | 2.95 | -- | 12.67 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Hyloris Pharmaceuticals SA | 2.81m | -15.76m | 327.60m | 24.00 | -- | 8.44 | -- | 116.42 | -0.5795 | -0.5795 | 0.1035 | 1.39 | 0.0514 | -- | 0.61 | -- | -28.80 | -22.79 | -32.58 | -28.07 | 96.70 | 93.79 | -560.13 | -640.15 | -- | -- | 0.0432 | -- | 44.23 | 98.64 | -33.92 | -- | 87.74 | -- |
| Blau Farmaceutica SA | 240.01m | 38.74m | 329.76m | 1.90k | 8.49 | 0.9933 | 7.23 | 1.37 | 1.33 | 1.33 | 8.24 | 11.37 | 0.5203 | 1.56 | 3.66 | 775,848.90 | 8.32 | 16.01 | 9.60 | 19.59 | 34.09 | 44.57 | 15.98 | 21.99 | 2.33 | -- | 0.2311 | 16.61 | -2.44 | 11.91 | -31.14 | 15.18 | 38.96 | -- |
Data as of Jul 26 2024. Currency figures normalised to Euroapi SA's reporting currency: Euro EUR
23.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kopernik Global Investors LLCas of 12 Mar 2024 | 4.98m | 5.21% |
| MAK Capital One LLCas of 08 Feb 2024 | 4.77m | 4.99% |
| CDC Croissance SAas of 26 Jan 2024 | 4.75m | 4.97% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 2.43m | 2.54% |
| Brandes Investment Partners LPas of 25 Jul 2024 | 1.44m | 1.50% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.03m | 1.08% |
| Cr�dit Mutuel Asset Management SAas of 29 Dec 2023 | 860.93k | 0.90% |
| DNCA Finance SAas of 29 Dec 2023 | 643.71k | 0.67% |
| Edmond de Rothschild Asset Management (France) SAas of 29 Sep 2023 | 630.61k | 0.66% |
| Niche Asset Management Ltd.as of 31 Dec 2023 | 625.20k | 0.65% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
